Insight to Advocacy Webinar Series


In 2021, IPA will provide engaging content from policymakers throughout the legislative session on a variety of prominent regulatory topics.
These webinars are accredited for Pharmacy Law CE. Register for individual webinars or all six! Fees apply for some membership levels.
 
 

February 19, 11:00 AM: Rutledge v. PCMA – Impact on State Legislation  

In October, the Supreme Court heard oral arguments in a case that could fundamentally alter the PBM landscape among the states. Hear from experts on how exactly the SCOTUS decision could impact state’s ability to regulate PBMs. 

Speakers: John Vinson, PharmD, CEO,
Arkansas Pharmacists Association; 
Matt Magner, JD, Director of State Government Affairs, National Community Pharmacists Association (NCPA); Casey Ficek, JD, Vice President of Public Affairs, IPA

CPE Course Details



March 5, 11:00 AM: First Funnel Update – What bills are still alive? 

Iowa’s “funnel” process means many bills are considered dead for the remainder of session. IPA’s Casey Ficek will provide an update on what pharmacy priorities are still alive and what bills failed to advance for the year.

Speaker:
Casey Ficek, JD, Vice President of Public Affairs, IPA


CPE Course Details



April 16, 11:00 AM: Practice Act Task Force Update

IPA and the Board of Pharmacy have begun the process of working to adopt a new Iowa Pharmacy Practice Act. Casey Ficek and Andrew Funk will provide an update on what work has been done so far and what else is needed in 2021. 

Speakers: Casey Ficek, JD, Vice President of Public Affairs, IPA; Andrew Funk, PharmD, Executive Director, Iowa BOP

CPE Course Details



May 14, 11:00 AM:
340B – Updates and Advocacy

Recent efforts from manufacturers to place limitations on the 340B Drug Pricing Program have resulted in renewed intensity and action from advocates to protect the 340B program. Hear from experts to learn what efforts are underway at the state and federal level to ensure this critical program remains protected. 

Speakers: 
Kyle Robb, PharmD, State Policy & Advocacy Associate, ASHP

**On Monday, May 17, 2021, HRSA released letters to the six pharmaceutical manufacturers (Eli Lilly, AstraZeneca, Novo Nordisk, Novartis, Sanofi, United Therapeutics) that have placed restrictions on deliveries to contract pharmacies, stating those restrictions are in violation of the 340B statute. HRSA stated the drug manufacturers must comply with its 340B statutory obligations. Read more at https://www.hrsa.gov/opa/.

CPE Course Details



June 18, 11:00 AM: Action Across the States – State Pharmacy Legislation

The National Alliance of State Pharmacy Association (NASPA) will provide an update on emerging trends for pharmacy in other state legislatures.

Speaker: Joni Cover, JD, Vice President of Strategic Initiatives, NASPA 

CPE Course Details



CANCELLED July 16, 11:00 AM: Updates from Congress – Hear from a member of Iowa’s Congressional Delegation